Pfizer Stock (NYSE:PFE)
An official from Pfizer (NYSE:PFE) testified on Monday in front of a special committee of the European Parliament, “categorically” refuted charges that the company’s Chief Executive negotiated a multibillion-dollar COVID-19 vaccine deal with the European Commission through text messages. As a result, Pfizer stock plunged in the market.
Pfizer (NYSE:PFE) President of International Developed Markets Janine Small led the efforts in negotiating the contract under which the Pfizer stock agreed to deliver 900 million doses of COVID shots with an option to supply another 900 million doses. The contract also included an option to supply another 900 million doses.
“I can certainly tell you that would not be the case,” stated Small in response to whether or not a contract discussion such as the deal you alluded to, which included 1.8 billion doses, was discussed over an SMS.
She said, “I am aware of this since I participated in all of the conversations and debates from the very beginning of the year 2020.”
Pfizer (NYSE:PFE) Chief Executive Officer Albert Bourla was reported by Politico in September to have declined an invitation to speak before a special committee entrusted with developing plans to react to future pandemics. The committee has previously heard from top officials and CEOs of companies that manufacture COVID-19 vaccines, including the Chief Executive Officer of Moderna and senior officials from AstraZeneca
In an interview given to The New York Times in April 2021, the President of the European Commission, Ursula von der Leyen, said that she and Bourla spoke through text message for one month before coming to an agreement.
However, the commission chose not to disclose the specifics of the documents, which led to a complaint from the European Ombudsman, the official watchdog of the European Union.
Featured Image- Megapixl @ Brasilnut
Author Shariq Khan 
